ID   UBP12_HUMAN             Reviewed;         370 AA.
AC   O75317; A8K0X0; Q5VZV3; Q8TC49;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 12;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 12;
DE   AltName: Full=Ubiquitin thioesterase 12;
DE   AltName: Full=Ubiquitin-hydrolyzing enzyme 1;
DE   AltName: Full=Ubiquitin-specific-processing protease 12;
GN   Name=USP12; Synonyms=UBH1, USP12L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9615226; DOI=10.1006/geno.1998.5275;
RA   Hansen-Hagge T.E., Janssen J.W.G., Hameister H., Papa F.R.,
RA   Zechner U., Seriu T., Jauch A., Becke D., Hochstrasser M.,
RA   Bartram C.R.;
RT   "An evolutionarily conserved gene on human chromosome 5q33-q34, UBH1,
RT   encodes a novel deubiquitinating enzyme.";
RL   Genomics 49:411-418(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, CATALYTIC ACTIVITY, FUNCTION,
RP   INTERACTION WITH WDR48, AND MUTAGENESIS OF CYS-48.
RX   PubMed=19075014; DOI=10.1074/jbc.M808430200;
RA   Cohn M.A., Kee Y., Haas W., Gygi S.P., D'Andrea A.D.;
RT   "UAF1 is a subunit of multiple deubiquitinating enzyme complexes.";
RL   J. Biol. Chem. 284:5343-5351(2009).
RN   [7]
RP   SUBUNIT, ENZYME REGULATION, AND INTERACTION WITH WDR20.
RX   PubMed=20147737; DOI=10.1074/jbc.M109.095141;
RA   Kee Y., Yang K., Cohn M.A., Haas W., Gygi S.P., D'Andrea A.D.;
RT   "WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme
RT   complex.";
RL   J. Biol. Chem. 285:11252-11257(2010).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH PHLPP1.
RX   PubMed=24145035; DOI=10.1074/jbc.M113.503383;
RA   Gangula N.R., Maddika S.;
RT   "WD repeat protein WDR48 in complex with deubiquitinase USP12
RT   suppresses Akt-dependent cell survival signaling by stabilizing PH
RT   domain leucine-rich repeat protein phosphatase 1 (PHLPP1).";
RL   J. Biol. Chem. 288:34545-34554(2013).
RN   [9] {ECO:0000244|PDB:5L8W}
RP   X-RAY CRYSTALLOGRAPHY (2.79 ANGSTROMS) IN COMPLEX WITH WDR48 AND
RP   UBIQUITIN, ZINC-BINDING, INTERACTION WITH WDR48, AND MUTAGENESIS OF
RP   GLU-190.
RX   PubMed=27650958; DOI=10.1016/j.jsb.2016.09.011;
RA   Dharadhar S., Clerici M., van Dijk W.J., Fish A., Sixma T.K.;
RT   "A conserved two-step binding for the UAF1 regulator to the USP12
RT   deubiquitinating enzyme.";
RL   J. Struct. Biol. 196:437-447(2016).
RN   [10] {ECO:0000244|PDB:5K16, ECO:0000244|PDB:5K1A, ECO:0000244|PDB:5K1B, ECO:0000244|PDB:5K1C}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 40-370 IN COMPLEX WITH WITH
RP   WDR20 AND WDR48, FUNCTION, ENZYME REGULATION, INTERACTION WITH WRD20
RP   AND WRD48, ZINC-BINDING, ACTIVE SITE, AND MUTAGENESIS OF CYS-48;
RP   208-GLN--THR-210; PHE-219; GLN-240; GLU-241; TYR-264; VAL-279 AND
RP   PHE-287.
RX   PubMed=27373336; DOI=10.1016/j.molcel.2016.05.031;
RA   Li H., Lim K.S., Kim H., Hinds T.R., Jo U., Mao H., Weller C.E.,
RA   Sun J., Chatterjee C., D'Andrea A.D., Zheng N.;
RT   "Allosteric activation of ubiquitin-specific proteases by beta-
RT   propeller proteins UAF1 and WDR20.";
RL   Mol. Cell 63:249-260(2016).
CC   -!- FUNCTION: Deubiquitinating enzyme. Has almost no deubiquitinating
CC       activity by itself and requires the interaction with WDR20 and
CC       WDR48 to have a high activity (PubMed:19075014, PubMed:27373336).
CC       Not involved in deubiquitination of monoubiquitinated FANCD2
CC       (PubMed:19075014). In complex with WDR48, acts as a potential
CC       tumor suppressor by positively regulating PHLPP1 stability
CC       (PubMed:24145035). {ECO:0000269|PubMed:19075014,
CC       ECO:0000269|PubMed:24145035, ECO:0000269|PubMed:27373336}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:19075014}.
CC   -!- ENZYME REGULATION: Activated by interaction with WDR20 and WDR48
CC       through different allosteric mechanisms.
CC       {ECO:0000269|PubMed:20147737, ECO:0000269|PubMed:27373336}.
CC   -!- SUBUNIT: Interacts with WDR48 (PubMed:19075014, PubMed:27650958,
CC       PubMed:27373336). Interacts with WDR20 (PubMed:20147737,
CC       PubMed:27373336). Component of the USP12/WDR20/WDR48
CC       deubiquitinating complex (PubMed:20147737, PubMed:27373336).
CC       Interacts with PHLPP1 (PubMed:24145035).
CC       {ECO:0000269|PubMed:19075014, ECO:0000269|PubMed:20147737,
CC       ECO:0000269|PubMed:24145035, ECO:0000269|PubMed:27373336,
CC       ECO:0000269|PubMed:27650958}.
CC   -!- INTERACTION:
CC       Q8TBZ3:WDR20; NbExp=4; IntAct=EBI-2511507, EBI-2511486;
CC   -!- MISCELLANEOUS: Knockdown of USP12 increases Akt activation.
CC       {ECO:0000269|PubMed:24145035}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP12/USP46
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC23551.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022789; AAC23551.1; ALT_INIT; mRNA.
DR   EMBL; AK289685; BAF82374.1; -; mRNA.
DR   EMBL; AL158062; CAH70555.1; -; Genomic_DNA.
DR   EMBL; AL355473; CAH70555.1; JOINED; Genomic_DNA.
DR   EMBL; AL355473; CAI16331.1; -; Genomic_DNA.
DR   EMBL; AL158062; CAI16331.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08392.1; -; Genomic_DNA.
DR   EMBL; BC026072; AAH26072.1; -; mRNA.
DR   CCDS; CCDS31952.1; -.
DR   RefSeq; NP_872294.2; NM_182488.3.
DR   UniGene; Hs.42400; -.
DR   PDB; 5K16; X-ray; 2.60 A; A/B=16-370.
DR   PDB; 5K1A; X-ray; 2.30 A; A/C/E/G=40-370.
DR   PDB; 5K1B; X-ray; 3.30 A; A=4-370.
DR   PDB; 5K1C; X-ray; 3.00 A; A=16-370.
DR   PDB; 5L8W; X-ray; 2.79 A; A=1-370.
DR   PDBsum; 5K16; -.
DR   PDBsum; 5K1A; -.
DR   PDBsum; 5K1B; -.
DR   PDBsum; 5K1C; -.
DR   PDBsum; 5L8W; -.
DR   ProteinModelPortal; O75317; -.
DR   SMR; O75317; -.
DR   BioGrid; 128522; 35.
DR   IntAct; O75317; 16.
DR   STRING; 9606.ENSP00000282344; -.
DR   MEROPS; C19.020; -.
DR   iPTMnet; O75317; -.
DR   PhosphoSitePlus; O75317; -.
DR   BioMuta; USP12; -.
DR   EPD; O75317; -.
DR   MaxQB; O75317; -.
DR   PaxDb; O75317; -.
DR   PeptideAtlas; O75317; -.
DR   PRIDE; O75317; -.
DR   Ensembl; ENST00000282344; ENSP00000282344; ENSG00000152484.
DR   GeneID; 219333; -.
DR   KEGG; hsa:219333; -.
DR   UCSC; uc001uqy.4; human.
DR   CTD; 219333; -.
DR   DisGeNET; 219333; -.
DR   GeneCards; USP12; -.
DR   HGNC; HGNC:20485; USP12.
DR   HPA; HPA007288; -.
DR   MIM; 603091; gene.
DR   neXtProt; NX_O75317; -.
DR   OpenTargets; ENSG00000152484; -.
DR   PharmGKB; PA37236; -.
DR   eggNOG; KOG1864; Eukaryota.
DR   eggNOG; ENOG410XQ81; LUCA.
DR   GeneTree; ENSGT00850000132276; -.
DR   HOGENOM; HOG000231498; -.
DR   HOVERGEN; HBG054038; -.
DR   InParanoid; O75317; -.
DR   KO; K11842; -.
DR   OMA; NENNSPP; -.
DR   OrthoDB; EOG091G0FC5; -.
DR   PhylomeDB; O75317; -.
DR   TreeFam; TF314144; -.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP12; human.
DR   GenomeRNAi; 219333; -.
DR   PRO; PR:O75317; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000152484; -.
DR   CleanEx; HS_USP12; -.
DR   ExpressionAtlas; O75317; baseline and differential.
DR   Genevisible; O75317; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF00443; UCH; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Hydrolase; Metal-binding; Protease;
KW   Reference proteome; Thiol protease; Ubl conjugation pathway; Zinc.
FT   CHAIN         1    370       Ubiquitin carboxyl-terminal hydrolase 12.
FT                                /FTId=PRO_0000080634.
FT   DOMAIN       39    369       USP.
FT   ACT_SITE     48     48       Nucleophile.
FT                                {ECO:0000269|PubMed:27373336}.
FT   ACT_SITE    317    317       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   METAL       186    186       Zinc. {ECO:0000244|PDB:5K16,
FT                                ECO:0000244|PDB:5K1A,
FT                                ECO:0000244|PDB:5K1B,
FT                                ECO:0000244|PDB:5L8W}.
FT   METAL       189    189       Zinc. {ECO:0000244|PDB:5K16,
FT                                ECO:0000244|PDB:5K1A,
FT                                ECO:0000244|PDB:5K1B,
FT                                ECO:0000244|PDB:5K1C,
FT                                ECO:0000244|PDB:5L8W}.
FT   METAL       233    233       Zinc. {ECO:0000244|PDB:5K16,
FT                                ECO:0000244|PDB:5K1A,
FT                                ECO:0000244|PDB:5K1B,
FT                                ECO:0000244|PDB:5K1C,
FT                                ECO:0000244|PDB:5L8W}.
FT   METAL       236    236       Zinc. {ECO:0000244|PDB:5K16,
FT                                ECO:0000244|PDB:5K1A,
FT                                ECO:0000244|PDB:5K1B,
FT                                ECO:0000244|PDB:5K1C,
FT                                ECO:0000244|PDB:5L8W}.
FT   MUTAGEN      48     48       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN      48     48       C->S: Loss of activity.
FT                                {ECO:0000269|PubMed:19075014}.
FT   MUTAGEN     190    190       E->K: Impaired binding to WDR48.
FT                                {ECO:0000269|PubMed:27650958}.
FT   MUTAGEN     208    210       QNT->GGG: Loss of activity.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     219    219       F->A: Loss of activity.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     240    240       Q->A: Impaired binding to WDR48; when
FT                                associated with Ala-241.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     241    241       E->A: Impaired binding to WDR48; when
FT                                associated with Ala-240.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     264    264       Y->A: Strong reduction of activity.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     279    279       V->D: Impaired binding to WDR20; when
FT                                associated with Ala-287.
FT                                {ECO:0000269|PubMed:27373336}.
FT   MUTAGEN     287    287       F->A: Impaired binding to WDR20; when
FT                                associated with Asp-279.
FT                                {ECO:0000269|PubMed:27373336}.
FT   CONFLICT    173    173       H -> D (in Ref. 5; AAH26072).
FT                                {ECO:0000305}.
FT   HELIX        22     27       {ECO:0000244|PDB:5K16}.
FT   TURN         29     31       {ECO:0000244|PDB:5K16}.
FT   STRAND       38     41       {ECO:0000244|PDB:5K16}.
FT   STRAND       42     46       {ECO:0000244|PDB:5K1A}.
FT   HELIX        47     58       {ECO:0000244|PDB:5K1A}.
FT   HELIX        61     68       {ECO:0000244|PDB:5K1A}.
FT   HELIX        81     92       {ECO:0000244|PDB:5K1A}.
FT   STRAND       95    101       {ECO:0000244|PDB:5K16}.
FT   HELIX       103    105       {ECO:0000244|PDB:5K1A}.
FT   HELIX       107    109       {ECO:0000244|PDB:5K1A}.
FT   HELIX       115    117       {ECO:0000244|PDB:5K16}.
FT   STRAND      119    121       {ECO:0000244|PDB:5K16}.
FT   HELIX       128    146       {ECO:0000244|PDB:5K1A}.
FT   HELIX       171    176       {ECO:0000244|PDB:5K1A}.
FT   STRAND      178    186       {ECO:0000244|PDB:5K1A}.
FT   TURN        187    189       {ECO:0000244|PDB:5K1A}.
FT   STRAND      192    204       {ECO:0000244|PDB:5K1A}.
FT   STRAND      208    211       {ECO:0000244|PDB:5K16}.
FT   HELIX       212    217       {ECO:0000244|PDB:5K1A}.
FT   STRAND      220    225       {ECO:0000244|PDB:5K1A}.
FT   HELIX       227    229       {ECO:0000244|PDB:5K1A}.
FT   STRAND      231    233       {ECO:0000244|PDB:5K1A}.
FT   TURN        234    237       {ECO:0000244|PDB:5K1A}.
FT   STRAND      238    240       {ECO:0000244|PDB:5K1A}.
FT   STRAND      242    250       {ECO:0000244|PDB:5K1A}.
FT   STRAND      253    259       {ECO:0000244|PDB:5K1A}.
FT   STRAND      262    265       {ECO:0000244|PDB:5K16}.
FT   TURN        266    269       {ECO:0000244|PDB:5K16}.
FT   STRAND      270    273       {ECO:0000244|PDB:5K16}.
FT   STRAND      282    285       {ECO:0000244|PDB:5K1A}.
FT   STRAND      299    308       {ECO:0000244|PDB:5K1A}.
FT   HELIX       312    314       {ECO:0000244|PDB:5K1A}.
FT   STRAND      317    324       {ECO:0000244|PDB:5K1A}.
FT   STRAND      327    332       {ECO:0000244|PDB:5K1A}.
FT   STRAND      335    339       {ECO:0000244|PDB:5K1A}.
FT   TURN        341    343       {ECO:0000244|PDB:5K1A}.
FT   HELIX       344    347       {ECO:0000244|PDB:5K1A}.
FT   STRAND      350    352       {ECO:0000244|PDB:5L8W}.
FT   STRAND      362    368       {ECO:0000244|PDB:5K1A}.
SQ   SEQUENCE   370 AA;  42858 MW;  267EE6A3674F6440 CRC64;
     MEILMTVSKF ASICTMGANA SALEKEIGPE QFPVNEHYFG LVNFGNTCYC NSVLQALYFC
     RPFREKVLAY KSQPRKKESL LTCLADLFHS IATQKKKVGV IPPKKFITRL RKENELFDNY
     MQQDAHEFLN YLLNTIADIL QEERKQEKQN GRLPNGNIDN ENNNSTPDPT WVHEIFQGTL
     TNETRCLTCE TISSKDEDFL DLSVDVEQNT SITHCLRGFS NTETLCSEYK YYCEECRSKQ
     EAHKRMKVKK LPMILALHLK RFKYMDQLHR YTKLSYRVVF PLELRLFNTS GDATNPDRMY
     DLVAVVVHCG SGPNRGHYIA IVKSHDFWLL FDDDIVEKID AQAIEEFYGL TSDISKNSES
     GYILFYQSRD
//
